Chinese medical device company Besman (BSME.US) has withdrawn its $20 million US stock IPO plan.

According to the Wisdom Financial APP, Chinese medical device company Bestman Precision Instruments (BSME.US) has withdrawn its IPO plan. The company had submitted an application for listing in February 2023, planning to issue 4 million shares of stock at a price range of 4 to 6 US dollars per share, intending to raise 20 million US dollars. If calculated at the midpoint of the proposed price range, its market value was originally expected to reach 95 million US dollars.